NPAideS: a drug-checking study among 3-methylmethcathinone (3-MMC) users

NPAideS: a drug-checking study among 3-methylmethcathinone (3-MMC) users

Abstract Background 3-methylmethcathinone (3-MMC) has been available on the European drug market for several years, but an increase in its availability seems to have occurred around 2020, associated with reports of harm and death. We aimed to analyze the composition of the supposed 3-MMC samples pur...

Full description

Bibliographic Details
Main Authors: Théo Willeman, Nathan Grundig, Christine Pochon, David Michels, Nicolas Charpentier, Hélène Eysseric-Guérin, Nathalie Fouilhé Sam-Lai, Françoise Stanke-Labesque, Bruno Revol
Format: Article
Language:English
Published: BMC 2023-07-01
Series:Harm Reduction Journal
Subjects:
Chemsex
3-methylmethcathinone
Harm reduction
Drug checking
Online Access:https://doi.org/10.1186/s12954-023-00836-4

Similar Items

Similar Items